Intérêt de la Vaccination HPV dans le Cancer du Col Utérin

Abstract

Cervical cancer is an infectious disease. It is the second most common cancer in women worldwide, mainly in developing countries, in terms of incidence and mortality. Cervical cancer continues to pose a real public health problem. It is infectious in origin: the papilloma virus is the main causative agent. The most effective way to prevent cervical cancer is to combine regular Pap smear screenings with vaccination. A Pap smear is a microscopic examination of cervical cells to look for abnormal cells and precancerous cells that may develop into cancerous lesions. The HPV test is a molecular search for the presence of viral DNA in the sample. This screening is for all women aged 25 to 65 and is performed by smear. The frequency is one smear every 3 years following 2 normal smears performed 1 year apart. A regular screening smear is currently the best way to avoid cervical cancer. Several vaccines are currently available that provide protection against the most common HPVs. Vaccination is strongly recommended for young girls: 11 to 14 years old and catch-up from 15 to 19 years old